• About Us
    • Overview
    • Management
    • Board of Directors
    • Contact Us
  • Products
    • Overview
    • LibiGel®
    • Elestrin™
    • The Pill-Plus™
    • Bio-T-Gel™
    • Cancer Vaccines
    • Market Data
  • Partners & Licenses
    • Overview
    • Opportunities
  • Therapeutic Areas
    • Female Sexual Dysfunction
    • Menopause
    • Contraception
    • Male Hypogonadism
    • Oncology
  • Investors
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Analyst Coverage
    • Request Information
  • Newsroom
    • News Releases
    • Webcasts
    • Media Kit

Improving health for life

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology.


LibiGel® is a transdermal testosterone gel in development for the treatment of female sexual dysfunction (FSD).

12/14/2011 – BioSante Pharmaceuticals Announces Results from LibiGel® Efficacy Trials 11/29/2011 – BioSante Pharmaceuticals Announces Issuance of New LibiGel® Method of Use Patent 11/21/2011 – BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index 11/16/2011 – BioSante Pharmaceuticals Announces Positive LibiGel® Pharmacokinetic Study Results
Copyright © BioSante Pharmaceuticals
Contact Us Site Map NASDAQ:BPAX Legal